was measured by noting the time in minutes required for the subject to taste a saccharin particle placed on the inferior turbinate of the naris. The CBF was determined by video microscopy on ten separate groups of beating ciliated nasal mucosal cells obtained by brushing immediately after each STT determination. We found that there was no significant change between Mucociliary clearance is an important host defense function of the airways. This function requires the coordinated beating of cilia which results in the transport of mucus to the oropharynx. Although the motor activity of cilia is certainly responsible in large part for the propulsion of mucus out of the airway, the linkage between ciliary motility and mucociliary clearance is poorly understood with no direct relationship described between the frequency of beating cilia and mucus clearance rates in man. 
METHODS
Clinical Data Subject Recruitment: The study protocol was approved by the Institutional Review Board at the University of Nebraska Medical Center prior to subject accrual. Ten healthy volunteers with a history of previous sinus problems were recruited through an advertisement to participate in the study. All subjects had no active sinus infection, nasal or sinus discharge, fevers, nasal stuffiness, or other active symptoms at the time of the study. Originally 12 subjects started the study, but one subject was not able to complete the study for personal reasons and another subject dropped out due to an exacerbation of asthma requiring oral steroid therapy. The remaining ten subjects were able to complete the entire study. Informed consent was obtained for all individuals at the time of enrollment.
Study Design: The study was a double-blind, placebo-controlled crossover study in which subjects were given guaifenesin, 400 mg orally, 5 times a day (2,000 mg/d) for 7 days either in the first or third week of the study and were given placebo during the opposite week. Guaifenesin and placebo were coded and dispensed by the pharmacy such that the subjects and investigators were blind to the code until the study was completed. The middle week (day 8 through 14) was a washout period when the subjects received no drugs. In vivo nasal STT and ex vivo CBF was determined on each subject 6 times throughout the study as indicated in Figure 1 .
Both tests were performed at the same time on each test day. In each case, the nasal STT was completed immediately prior to the nasal brushings. Out of 60 possible paired STT and CBF measurements, 48 were successfully completed. Difficulty in saccharin particle placement precluded STT determination in five instances, and inadequate nasal tissue obtained by brushing precluded CBF determination in eight instances. Eight of the ten subjects successfully completed paired measurements of STT and CBF, allowing analysis of both pre-and post-drug values of both parameters for the guaifenesin and placebo treatment periods.
Nasal Saccharin Transit Time: The nasal STT was measured using a standard protocol as described. 4 Briefly, the more patent naris was subjectively determined by the subject prior to the study, and the saccharin was placed in this naris for all subsequent determinations throughout the study. A 5-mg particle of saccharin measuring approximately 0.5 mm in diameter was placed on the inferior turbinate of the appropriate naris under direct visualization using a headlamp and a nasal speculum. After correct particle placement was visually confirmed, a stopwatch was started and the total time was recorded from initial particle placement until the subject was able to clearly taste sweetness. If the subject was unable to taste any sweetness after 30 min, an additional particle of saccharin was placed on the anterior aspect of the subject's tongue to exclude taste loss. In all determinations, the subjects had intact taste.
Ex Vivo Ciliary Beat Frequency: Immediately following completion of the STT determination, the right and left nares were brushed vigorously with a 2-mm diameter nylon cytology brush for approximately 5 s in each naris on the inferior turbinate.5 The brush immediately was rinsed in medium 199 and the cells were maintained at a constant temperature of 370C while being transported to the laboratory. The cells were resuspended upon arrival at the laboratory; they were placed on a glass slide with a coverslip and examined by phase-contrast microscopy. The temperature of the microscope stage was maintained electronically at 370C with a heated stage throughout the experiment. The sample was examined for ten separate groups of beating ciliated cells, and CBF was determined by recording the fields on videotape and performing frame-by-frame slow-motion video analysis as described.6
Statistical Analysis
All pre-and post-drug comparisons were made using the paired Student's t test. The relationships between STT and CBF were determined using a linear regression statistic.
RESU7LTS
Effect Fig 2, B) . When the change over seven days of treatment for guaifenesin was compared with the change with placebo relative to the baseline STT, there also was no significant difference between guaifenesin and placebo (guaifenesin, -0.8 ± 1.4 min vs placebo, -1.3±1.6 min; p=0.46; Fig 2, C) .
Effect of Guaifenesin and Placebo on Ciliary Beat Frequency
The effect of guaifenesin on CBF also was examined. The mean CBF from each individual prior to guaifenesin (day 0 or 14) was compared with the mean CBF at the end of the 7 days of guaifenesin treatment (day 7 or 21). There was no significant change in CBF pre-to post-drug (pre, 9.4 ± 0.4 Hz vs post, 9.2±0.4 Hz; p=0.39; Fig 3, A) . This was similar to the results obtained for placebo in which CBF also did not change significantly (pre, 9.8 ± 1.1 Hz vs post, 9.9 ±0.5 Hz; p=0.87; Fig 3, B) . The change in CBF after 7 days on the drug compared with baseline also was not significantly different (guaifenesin, -0.3 ± 0.4 Hz vs placebo, 0.1 + 0.9 Hz; p=0.46; Fig   3, C) (Fig 4) . Again, the same explanations could support this lack of a linear relationship. In summary, we conclude that guaifenesin has no significant impact on either nasal STT or ex vivo CBF in healthy volunteers with a previous history of sinus disease. Nasal STT and ex vivo CBF appear to be independent measures of mucociliary function, which are most likely to be related to sampling artifacts introduced by the nasal brushing technique or the ex vivo nature of the CBF assay.
